Pulse Biosciences, Inc. (PLSE) Analyst Estimates Quarterly

Pulse Biosciences, Inc.

PLSE (NASDAQ)

(%)

Annual Quarterly

* (except for per share items) of USD

Period Ending:	2026 12-30	2025 12-30	2025 09-30	2022 09-29	2022 06-29	2022 03-29	2021 12-29	2021 09-29	2021 06-29
Number of Analysts	1234	1	1	1	1	1	1	1	1
Estimated Revenue
Low	1234	0.125	0.5	0.2	0.44	0.715	0.872	0.189	0.034
Average	1234	0.125	0.5	0.2	0.44	0.715	0.872	0.189	0.034
High	1234	0.125	0.5	0.2	0.44	0.715	0.872	0.189	0.034
Estimated EBITDA
Low	1234	0.025	0.1	-17.18	-14.71	0.143	0.174	-18.38	-23.57
Average	1234	0.025	0.1	-14.32	-12.26	0.143	0.174	-15.32	-19.64
High	1234	0.025	0.1	-11.46	-9.81	0.143	0.174	-12.25	-15.71
Estimated EBIT
Low	1234	0.025	0.1	-17.53	-15.14	0.143	0.174	-18.74	-24.03
Average	1234	0.025	0.1	-14.6	-12.61	0.143	0.174	-15.62	-20.02
High	1234	0.025	0.1	-11.68	-10.09	0.143	0.174	-12.5	-16.02
Estimated Net Income
Low	1234	-17.86	-20.89	-17.54	-15.12	-35.26	-34.37	-18.76	-24.87
Average	1234	-17.86	-20.89	-14.61	-12.6	-35.26	-34.37	-15.63	-20.72
High	1234	-17.86	-20.89	-11.69	-10.08	-35.26	-34.37	-12.5	-16.58
Estimated SGA Expenses
Low	1234	1.6	6.4	2.56	5.62	9.15	11.15	2.41	0.437
Average	1234	1.6	6.4	2.56	5.62	9.15	11.15	2.41	0.437
High	1234	1.6	6.4	2.56	5.62	9.15	11.15	2.41	0.437
Estimated EPS
Low	1234	-0.265	-0.31	-0.45	-0.397	-0.523	-0.51	-0.533	-0.693
Average	1234	-0.265	-0.31	-0.45	-0.397	-0.523	-0.51	-0.533	-0.693
High	1234	-0.265	-0.31	-0.45	-0.397	-0.523	-0.51	-0.533	-0.693

Market is Open